Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anesthetic Greater Occipital Nerve Blockade in Veterans With Post-Traumatic Headache: Sub-study 2
NCT07796074Phase 2Recruiting
- Sponsor
- Yale University
- Start
- Sep 2026
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
Phase 2, randomised trial of bupivacaine hydrochloride 0.75% injection in post-traumatic headache (PTH) (3 arms), sponsored by Yale University. Primary endpoint: Change in headache days/week at 1 month. Started Sep 2026; status: recruiting.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
post-traumatic headache (PTH)
Beyond the preview
Go deeper on NCT07796074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07796074.